Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BC-819 |
Trade Name | |
Synonyms | BC819|BC 819|Inodiftagene vixteplasmid |
Drug Descriptions |
BC-819 (Inodiftagene vixteplasmid) is a recombinant DNA construct encoding an engineered diphtheria toxin that is specifically toxic to bladder cancer cells (Journal of Clinical Oncology 36, no. 6_suppl (February 20 2018) 499-499). |
DrugClasses | |
CAS Registry Number | 2166100-08-7 |
NCIT ID | C157333 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BC-819 | BC-819 | 0 | 0 |
BC-819 + BCG solution | BC-819 BCG solution | 0 | 0 |